It appears no script is enabled within your browser. Please enable JavaScript to use this site.
Skip header and navigation
Home
View Selections:
0
Items
Help
Print
Diane-35 (cyproterone acetate): safety concerns.
https://arctichealth.org/en/permalink/ahliterature186611
Source
CMAJ. 2003 Feb 18;168(4):455-6
Publication Type
Article
Date
Feb-18-2003
More detail
Author
Eric Wooltorton
Source
CMAJ. 2003 Feb 18;168(4):455-6
Date
Feb-18-2003
Language
English
Publication Type
Article
Keywords
Androgen Antagonists - adverse effects - standards
Canada
Consumer Product Safety
Contraceptives, Oral, Hormonal - adverse effects - standards
Cyproterone Acetate - adverse effects - standards
Drug Combinations
Ethinyl Estradiol - adverse effects - standards
Female
Great Britain
Humans
Risk factors
Venous Thrombosis - chemically induced - epidemiology
Women's health
Notes
Cites: N Engl J Med. 2001 May 17;344(20):1527-3511357157
Cites: BMJ. 2001 Jul 21;323(7305):131-411463678
Cites: Lancet. 2001 Oct 27;358(9291):1427-911705493
Cites: Contraception. 2002 Mar;65(3):187-9611929640
Cites: CMAJ. 2002 Apr 2;166(7):93111949993
Cites: CMAJ. 2002 Jul 9;167(1):48-5412137081
Cites: BMJ. 2000 Nov 11;321(7270):1190-511073511
Cites: BMJ. 2000 Jul 22;321(7255):190-110903631
Cites: Lancet. 2000 Jun 17;355(9221):2133-410902629
Cites: Lancet. 1995 Dec 16;346(8990):1575-827500748
Cites: Contraception. 1998 Jan;57(1):61-59554253
Cites: BMJ. 1996 Jan 13;312(7023):121-28555906
Cites: Lancet. 1995 Dec 16;346(8990):1589-937500750
Comment In: CMAJ. 2003 May 27;168(11):139412771065
PubMed ID
12591790
View in PubMed
Less detail
Permalink